Valproic Acid and Thrombocytopenia

The association of thrombocytopenia (TCP) with valproic acid (VPA) therapy was evaluated retrospectively in 167 children treated with VPA between 1989 and 1993 at the Department of Pediatrics, Henry Ford Medical Center, Detroit, MI.

Bibliographic Details
Published in:	Pediatric Neurology Briefs
Main Author:	J Gordon Millichap
Format:	Article
Language:	English
Published:	Pediatric Neurology Briefs Publishers 1996-08-01
Subjects:	thrombocytopenia valproic acid hydrocephalus
Online Access:	https://www.pediatricneurologybriefs.com/articles/3786

Similar Items

Risk factors for thrombocytopenia associated with intravenous valproic acid therapy in pediatric patients undergoing neurosurgical operations
by: Zhaosong Du, et al.
Published: (2025-04-01)

Ammonia Blood Levels and Valproic Acid
by: J Gordon Millichap
Published: (2007-12-01)

Hepatic Fatalities and Valproic Acid
by: J Gordon Millichap
Published: (1996-04-01)

Valproate-induced thrombocytopenia
by: N. V. Izmozherova, et al.
Published: (2024-04-01)

Hallucinations after Valproic Acid Withdrawal
by: J Gordon Millichap
Published: (2012-08-01)

Choreiform Movements and Valproic Acid
by: J Gordon Millichap
Published: (1994-08-01)

Valproic Acid and Carnitine Metabolism
by: J Gordon Millichap
Published: (1991-11-01)

Valproic Acid-Induced Hair Curling
by: J Gordon Millichap
Published: (2007-03-01)

Thrombophilic Risk Factors with Valproic Acid
by: J Gordon Millichap
Published: (2009-02-01)

Valproic Acid and Sleep Duration in Children with Epilepsy
by: J Gordon Millichap
Published: (2009-09-01)

Neonatal Intractable Seizures and Valproic acid Therapy
by: J Gordon Millichap
Published: (1988-03-01)

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
by: J Gordon Millichap
Published: (2010-03-01)

Long-Term Effectiveness of Ethosuximide, Valproic Acid and Lamotrigine in Absence Epilepsy
by: J Gordon Millichap
Published: (2012-06-01)

Nomogram for the prediction of valproic acid induced platelet decline: a nested case–control study
by: Gang Cheng, et al.
Published: (2025-03-01)

Reversible Altered Consciousness and Brain Atrophy Induced by Valproic Acid
by: J Gordon Millichap
Published: (2003-08-01)

Valproic Acid-induced Agranulocytosis
by: Hui-Chuan Hsu, et al.
Published: (2009-06-01)

Severe Valproic Acid Intoxication Responding to Hemodialysis
by: Ali Ertuğ Arslanköylü, et al.
Published: (2017-08-01)

Current Views on the Use of Valproic Acid in Women
by: Kezban ASLAN KARA, et al.
Published: (2019-08-01)

Valproic acid-induced hyperammonemic encephalopathy: a clinical case
by: M. Felizardo, et al.
Published: (2022-06-01)

A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid
by: Ayesha Safdar, et al.
Published: (2023-02-01)

Acute pancreatitis induced by valproic acid
by: S. Khouadja, et al.
Published: (2021-04-01)

Frequency of Subclinic Hypothyroidism at the Patients That Are Using Valproic Acid
by: Mehmet Ibrahim Turan, et al.
Published: (2014-06-01)

Nail Hyperpigmentation Following Valproic Acid Use: A Rare Case Report
by: Jitendriya Biswal, et al.
Published: (2023-02-01)

An ode to valproic acid: A letter to the editor
by: Anna P. Shapiro-Krew, et al.
Published: (2024-01-01)

Fatal Hyperammonemic Brain Injury from Valproic Acid Exposure
by: Danny Bega, et al.
Published: (2012-12-01)

DISSOLUTION PROFILE STUDY FOR EXTENDED RELEASE VALPROIC ACID DOSAGE FORM (DEPAKINE® CHRONO)
by: A. A. Lvova, et al.
Published: (2019-01-01)

Valproic Acid and Its Amidic Derivatives as New Antivirals against Alphaherpesviruses
by: Sabina Andreu, et al.
Published: (2020-11-01)

Carbapenems as Antidotes for the Management of Acute Valproic Acid Poisoning
by: Nataša Perković Vukčević, et al.
Published: (2024-02-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

Valproic acid: Does it have an antiarrhythmic action?
by: Osama Shukir Muhammed Amin, et al.
Published: (2013-08-01)

Genetic Polymorphisms Associated with Valproic Acid Therapy: Review article
by: Reham A.M. Ellisy*, et al.
Published: (2022-07-01)

Use of valproic acid in long stay units of psychiatry
by: Mª Teresa Martínez-Lazcano, et al.
Published: (2015-01-01)

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile
by: Manish Kumar Mishra, et al.
Published: (2021-12-01)

Neutropenia induced by Valproic Acid: A case report
by: N. Baldaquí, et al.
Published: (2022-06-01)

Chronic valproic acid intoxication in epileptology: diagnosis and treatment
by: N. A. Shnaider, et al.
Published: (2016-07-01)

The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
by: Yussra Ata Yaseen Abdulqader, et al.
Published: (2021-05-01)

Drug Interaction Between Valproic Acid and Meropenem: A Case Report
by: Murat Yaşar Özkalkanlı, et al.
Published: (2015-04-01)

Pentylenetetrazole-induced seizures in developing rats prenatally exposed to valproic acid
by: Angel A. Puig-Lagunes, et al.
Published: (2016-11-01)

Levetiracetam and Valproic Acid: Effects on the Liver Functions and Ammonia Level in Children
by: Faruk Incecik, et al.
Published: (2014-02-01)

Serum Leptin Levels in Epileptic Patients Treated with Topiramate and Valproic Acid
by: İrem Fatma Uludağ, et al.
Published: (2011-03-01)